Search for Clinical Trial Results

Sponsored By

Blood Coagulation Disorders, Inherited - 23 Studies Found

Status Study
Completed Study Name: Alphanate in Immune Tolerance Induction Therapy
Condition: Hemophilia A, Congenital
Date: 2017-03-23
Interventions: Biological: Alphanate Daily intravenous infusion of Alphanate 100 IU/kg/day
Not yet recruiting Study Name: A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment
Condition: Hemophilia A
Date: 2017-03-10
Interventions: Biological: rFVIIIFc rFVIIIFc 200 IU/kg/day in ITI Period and 50 or 100 IU/kg (adjusted according to Inv
Completed Study Name: Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency
Condition: Factor VII Deficiency
Date: 2017-03-04
Interventions:
  • Biological: Eptacog alfa, biosimilar and reference medicinal product Novosev
Not yet recruiting Study Name: Dose-Ranging Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 in Subjects With Severe Hemophilia A
Condition: Hemophilia A
Date: 2017-02-15
Interventions: Biological: SB-525 Single dose of investigational product SB-525
Completed Study Name: Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
Condition:
  • Haemophilia
  • Developing Countries

Date: 2017-02-13
Interventions:
  • Other: Education Education of

Active, not recruiting Study Name: Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe
Condition:
  • Factor VIII Deficiency, Congenital
  • Factor 8 Deficiency, Congenital
  • Hemophilia A
  • Hemophilia
  • Factor VIII Deficiency

Date: 2016-12-22
Interventions: Drug: Octocog Alfa Other Names:
  • Advate®
  • Human Factor VIII
Not yet recruiting Study Name: Individualizing Hemophilia Bypassing Agent Therapy Utilizing Thromboelastography
Condition: Hemophilia A With Inhibitors
Date: 2016-12-19
Interventions: Other: Thromboelastography-Guided Treatment Regimen The thromboelastograph (TEG) will be used to determi
Not yet recruiting Study Name: Gene Therapy for Haemophilia A.
Condition:
Date: 2025-11-04
<<< Previous | Next >>>